Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women

ClinicalTrials.gov ID: NCT03475706

Public ClinicalTrials.gov record NCT03475706. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Oral Solabegron Immediate Release Tablets in the Treatment of Overactive Bladder (OAB) in Adult Female Subjects

Study identification

NCT ID
NCT03475706
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Velicept Therapeutics, Inc.
Industry
Enrollment
438 participants

Conditions and interventions

Interventions

  • Solabegron immediate release tablets, low dose Drug
  • Solabegron immediate release tablets, high dose Drug
  • Matching Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 18, 2018
Primary completion
Jan 23, 2019
Completion
Jan 29, 2019
Last update posted
Mar 1, 2020

2018 – 2019

United States locations

U.S. sites
86
U.S. states
32
U.S. cities
80
Facility City State ZIP Site status
Velicept Investigative Site - Birmingham Birmingham Alabama 35205
Velicept Investigative Site - Gulf Shores Gulf Shores Alabama 36542
Velicept Investigative Site - Mobile Mobile Alabama 36608
Velicept Investigative Site - Tempe Tempe Arizona 85283
Velicept Investigative Site - Tucson Tucson Arizona 87504
Velicept Investigative Site - Little Rock Little Rock Arkansas 72212
Velicept Investigative Site - Anaheim Anaheim California 92801
Velicept Investigative Site - Arcadia Arcadia California 91007
Velicept Investigative Site - Canoga Park Canoga Park California 91303
Velicept Investigative Site - Huntington Beach Huntington Beach California 92647
Velicept Investigative Site - Los Alamitos Los Alamitos California 90720
Velicept Investigative Site - Los Angeles Los Angeles California 90017
Velicept Investigative Site - Norco Norco California 92860
Velicept Investigative Site - Sacramento Sacramento California 95821
Velicept Investigative Site - San Diego San Diego California 92103
Velicept Investigative Site - San Diego San Diego California 92123
Velicept Investigative Site - San Marcos San Marcos California 92078
Velicept Investigative Site - Thousand Oaks Thousand Oaks California 91360
Velicept Investigative Site - Denver Denver Colorado 80209
Velicept Investigative Site - Waterbury Waterbury Connecticut 06708
Velicept Investigative Site - Clearwater Clearwater Florida 33761
Velicept Investigative Site - Deland DeLand Florida 32720
Velicept Investigative Site - Doral Doral Florida 33166
Velicept Investigative Site - Jupiter Jupiter Florida 33458
Velicept Investigative Site - Lake City Lake City Florida 32055
Velicept Investigative Site - Miami Miami Florida 33135
Velicept Investigative Site - Miami Miami Florida 33176
Velicept Investigative Site - Miami Miami Florida 33186
Velicept Investigative Site - Ponte Vedra Ponte Vedra Florida 32081
Velicept Investigative Site - Port St Lucie Port Saint Lucie Florida 34952
Velicept Investigative Site - West Palm Beach West Palm Beach Florida 33409
Velicept Investigative Site - Winter Haven Winter Haven Florida 33880
Velicept Investigative Site - Marietta Marietta Georgia 30060
Velicept Investigative Site - Blackfoot Blackfoot Idaho 83221
Velicept Investigative Site - Meridian Meridian Idaho 83642
Velicept Investigative Site - Wauconda Wauconda Illinois 60084
Velicept Investigative Site - Elwood Elwood Indiana 46036
Velicept Investigative Site - Evansville Evansville Indiana 47714
Velicept Investigative Site - Newton Newton Kansas 67114
Velicept Investigative Site - Louisville Louisville Kentucky 40291
Velicept Investigative Site - Metairie Metairie Louisiana 70001
Velicept Investigative Site - New Orleans New Orleans Louisiana 70115
Velicept Investigative Site - Shreveport Shreveport Louisiana 71106
Velicept Investigative Site - Boston Boston Massachusetts 02131
Velicept Investigative Site - New Bedford New Bedford Massachusetts 02740
Velicept Investigative Site - North Attleborro North Attleboro Massachusetts 02760
Velicept Investigative Site - Watertown Watertown Massachusetts 02472
Velicept Investigative Site - Kalamazoo Kalamazoo Michigan 49009
Velicept Investigative Site - St. Louis St Louis Missouri 63141
Velicept Investigative Site - Omaha Omaha Nebraska 68114
Velicept Investigative Site - Las Vegas Las Vegas Nevada 89119
Velicept Investigative Site - Brick Brick New Jersey 08724
Velicept Investigative Site - Vorhees Voorhees Township New Jersey 08043
Velicept Investigative Site - Albuquerque Albuquerque New Mexico 87102
Velicept Investigative Site - New York New York New York 10016
Velicept Investigative Site - Williamsville Williamsville New York 14221
Velicept Investigative Site - Charlotte Charlotte North Carolina 28203
Velicept Investigative Site - Wilmington Wilmington North Carolina 28401
Velicept Investigative Site - Winston-Salem Winston-Salem North Carolina 27103
Velicept Investigative Site - Cincinnati Cincinnati Ohio 45236
Velicept Investigative Site - Cleveland Cleveland Ohio 44122
Velicept Investigative Site - Columbus Columbus Ohio 43123
Velicept Investigative Site - Marion Marion Ohio 43302
Velicept Investigative Site - Middleburg Heights Middleburg Heights Ohio 44130
Velicept Investigative Site - Warwick Warwick Rhode Island 02818
Velicept Investigative Site - Mt. Pleasant Mt. Pleasant South Carolina 29464
Velicept Investigative Site - Myrtle Beach Myrtle Beach South Carolina 29572
Velicept Investigative Site - Jackson Jackson Tennessee 38305
Velicept Investigative Site - Knoxville Knoxville Tennessee 37920
Velicept Investigative Site - Nashville Nashville Tennessee 37203
Velicept Investigative Site - Austin Austin Texas 78735
Velicept Investigative Site - Beaumont Beaumont Texas 77702
Velicept Investigative Site - Lampasas Lampasas Texas 76550
Velicept Investigative Site - Longview Longview Texas 80209
Velicept Investigative Site - San Antonio San Antonio Texas 78209
Velicept Investigative Site - San Antonio San Antonio Texas 78229
Velicept Investigative Site - San Antonio San Antonio Texas 78249
Velicept Investigative Site - Clinton Clinton Utah 84015
Velicept Investigative Site - Salt Lake City Salt Lake City Utah 84107
Velicept Investigative Site - Salt Lake City Salt Lake City Utah 84124
Velicept Investigative Site - St. George St. George Utah 84790
Velicept Investigative Site - West Jordan West Jordan Utah 84088
Velicept Investigative Site - Newport News Newport News Virginia 23606
Velicept Investigative Site - Norfolk Norfolk Virginia 23507
Velicept Investigative Site - Tacoma Tacoma Washington 98405
Velicept Investigative Site - Kenosha Kenosha Wisconsin 53142

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03475706, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 1, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03475706 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →